{
  "DOI": "10.1186/s40246-017-0109-3",
  "ISSN": [
    "1479-7364"
  ],
  "URL": "http://dx.doi.org/10.1186/s40246-017-0109-3",
  "alternative-id": [
    "109"
  ],
  "article-number": "13",
  "author": [
    {
      "affiliation": [],
      "family": "Philpott",
      "given": "Charlotte",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Tovell",
      "given": "Hannah",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Frayling",
      "given": "Ian M.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Cooper",
      "given": "David N.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Upadhyaya",
      "given": "Meena",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genomics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2017,
        6,
        21
      ]
    ],
    "date-time": "2017-06-21T12:37:56Z",
    "timestamp": 1498048676000
  },
  "deposited": {
    "date-parts": [
      [
        2020,
        10,
        10
      ]
    ],
    "date-time": "2020-10-10T16:03:27Z",
    "timestamp": 1602345807000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        30
      ]
    ],
    "date-time": "2024-04-30T10:34:34Z",
    "timestamp": 1714473274671
  },
  "is-referenced-by-count": 187,
  "issn-type": [
    {
      "type": "electronic",
      "value": "1479-7364"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2017,
        6,
        21
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-print": {
      "date-parts": [
        [
          2017,
          12
        ]
      ]
    }
  },
  "language": "en",
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1186/s40246-017-0109-3.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "prefix": "10.1186",
  "published": {
    "date-parts": [
      [
        2017,
        6,
        21
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2017,
        6,
        21
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2017,
        12
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "author": "E Bennett",
      "first-page": "105",
      "issue": "2",
      "journal-title": "J Pediatr Neurol",
      "key": "109_CR1",
      "unstructured": "Bennett E, Thomas N, Upadhyaya M. Neurofibromatosis type 1: its association with the Ras/MAPK pathway syndromes. J Pediatr Neurol. 2009;7(2):105–15.",
      "volume": "7",
      "year": "2009"
    },
    {
      "DOI": "10.1007/978-3-642-32864-0_10",
      "author": "DN Cooper",
      "doi-asserted-by": "crossref",
      "first-page": "115",
      "key": "109_CR2",
      "unstructured": "Cooper DN, Upadhyaya M. The germline mutational spectrum in neurofibromatosis type 1 and genotype-phenotype correlations, Chapter 10. In: Upadhyaya M, Cooper DN, editors. Neurofibromatosis Type 1, vol. Chapter 10. Berlin: Springer Verlag; 2012. p. 115–34.",
      "volume-title": "Neurofibromatosis Type 1",
      "year": "2012"
    },
    {
      "DOI": "10.1136/jmg.26.11.704",
      "author": "SM Huson",
      "doi-asserted-by": "crossref",
      "first-page": "704",
      "issue": "11",
      "journal-title": "J Med Genet",
      "key": "109_CR3",
      "unstructured": "Huson SM, Compston DA, Clark P, Harper PS. A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity. J Med Genet. 1989;26(11):704–11.",
      "volume": "26",
      "year": "1989"
    },
    {
      "DOI": "10.1001/archderm.141.1.71",
      "author": "M Lammert",
      "doi-asserted-by": "crossref",
      "first-page": "71",
      "issue": "1",
      "journal-title": "Arch Dermatol",
      "key": "109_CR4",
      "unstructured": "Lammert M, Friedman JM, Kluwe L, Mautner VF. Prevalence of neurofibromatosis 1 in German children at elementary school enrollment. Arch Dermatol. 2005;141(1):71–4.",
      "volume": "141",
      "year": "2005"
    },
    {
      "DOI": "10.1086/510781",
      "author": "M Upadhyaya",
      "doi-asserted-by": "crossref",
      "first-page": "140",
      "issue": "1",
      "journal-title": "Am J Hum Genet",
      "key": "109_CR5",
      "unstructured": "Upadhyaya M, Huson SM, Davies M, Thomas N, Chuzhanova N, Giovannini S, Evans DG, Howard E, Kerr B, Griffiths S, et al. An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation. Am J Hum Genet. 2007;80(1):140–51.",
      "volume": "80",
      "year": "2007"
    },
    {
      "DOI": "10.2741/3727",
      "author": "M Upadhyaya",
      "doi-asserted-by": "crossref",
      "first-page": "937",
      "journal-title": "Front Biosci (Landmark Ed)",
      "key": "109_CR6",
      "unstructured": "Upadhyaya M. Genetic basis of tumorigenesis in NF1 malignant peripheral nerve sheath tumors. Front Biosci (Landmark Ed). 2011;16:937–51.",
      "volume": "16",
      "year": "2011"
    },
    {
      "DOI": "10.1002/humu.20601",
      "doi-asserted-by": "crossref",
      "key": "109_CR7",
      "unstructured": "Upadhyaya M, Kluwe L, Spurlock G, Monem B, Majounie E, Mantripragada K, Ruggieri M, Chuzhanova N, Evans DG, Ferner R, Thomas N, Guha A, Mautner V. Germline and somatic NF1 gene mutation spectrum in NF1-associated malignant peripheral nerve sheath tumors (MPNSTs). Hum Mutat. 2008;29(1):74–82. "
    },
    {
      "DOI": "10.1038/sj.bjc.6603227",
      "author": "L Walker",
      "doi-asserted-by": "crossref",
      "first-page": "233",
      "issue": "2",
      "journal-title": "Br J Cancer",
      "key": "109_CR8",
      "unstructured": "Walker L, Thompson D, Easton D, Ponder B, Ponder M, Frayling I, Baralle D. A prospective study of neurofibromatosis type 1 cancer incidence in the UK. Br J Cancer. 2006;95(2):233–8.",
      "volume": "95",
      "year": "2006"
    },
    {
      "DOI": "10.1016/S1470-2045(09)70033-6",
      "author": "H Brems",
      "doi-asserted-by": "crossref",
      "first-page": "508",
      "issue": "5",
      "journal-title": "Lancet Oncol",
      "key": "109_CR9",
      "unstructured": "Brems H, Beert E, de Ravel T, Legius E. Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1. Lancet Oncol. 2009;10(5):508–15.",
      "volume": "10",
      "year": "2009"
    },
    {
      "DOI": "10.1073/pnas.68.4.820",
      "author": "AG Knudson Jr",
      "doi-asserted-by": "crossref",
      "first-page": "820",
      "issue": "4",
      "journal-title": "Proc Natl Acad Sci U S A",
      "key": "109_CR10",
      "unstructured": "Knudson Jr AG. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A. 1971;68(4):820–3.",
      "volume": "68",
      "year": "1971"
    },
    {
      "DOI": "10.1016/0092-8674(90)90252-A",
      "author": "D Viskochil",
      "doi-asserted-by": "crossref",
      "first-page": "187",
      "issue": "1",
      "journal-title": "Cell",
      "key": "109_CR11",
      "unstructured": "Viskochil D, Buchberg AM, Xu G, Cawthon RM, Stevens J, Wolff RK, Culver M, Carey JC, Copeland NG, Jenkins NA, et al. Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell. 1990;62(1):187–92.",
      "volume": "62",
      "year": "1990"
    },
    {
      "DOI": "10.1016/S0092-8674(01)00245-8",
      "author": "K Cichowski",
      "doi-asserted-by": "crossref",
      "first-page": "593",
      "issue": "4",
      "journal-title": "Cell",
      "key": "109_CR12",
      "unstructured": "Cichowski K, Jacks T. NF1 tumor suppressor gene function: narrowing the GAP. Cell. 2001;104(4):593–604.",
      "volume": "104",
      "year": "2001"
    },
    {
      "DOI": "10.1146/annurev.pathol.2.010506.091940",
      "author": "AI McClatchey",
      "doi-asserted-by": "crossref",
      "first-page": "191",
      "journal-title": "Annu Rev Pathol",
      "key": "109_CR13",
      "unstructured": "McClatchey AI. Neurofibromatosis. Annu Rev Pathol. 2007;2:191–216.",
      "volume": "2",
      "year": "2007"
    },
    {
      "DOI": "10.1159/000126561",
      "doi-asserted-by": "crossref",
      "key": "109_CR14",
      "unstructured": "Welti S, D’Angelo I, Scheffzek K. Structure and function of neurofibromin. In: Neurofibromatoses. Basel: Karger; 2008:113–28."
    },
    {
      "DOI": "10.1016/j.febslet.2012.06.006",
      "author": "K Scheffzek",
      "doi-asserted-by": "crossref",
      "first-page": "2662",
      "issue": "17",
      "journal-title": "FEBS Lett",
      "key": "109_CR15",
      "unstructured": "Scheffzek K, Welti S. Pleckstrin homology (PH) like domains—versatile modules in protein-protein interaction platforms. FEBS Lett. 2012;586(17):2662–73.",
      "volume": "586",
      "year": "2012"
    },
    {
      "DOI": "10.1007/978-3-642-32864-0_20",
      "author": "K Scheffzek",
      "doi-asserted-by": "crossref",
      "first-page": "305",
      "key": "109_CR16",
      "unstructured": "Scheffzek K, Welti S. Neurofibromin: protein domains and functional characteristics. In: Upadhyaya M, Cooper DN, editors. Neurofibromatosis Type 1. Berlin Heidelberg: Springer; 2012. p. 305–26.",
      "volume-title": "Neurofibromatosis Type 1",
      "year": "2012"
    },
    {
      "DOI": "10.1073/pnas.0503224102",
      "author": "CM Johannessen",
      "doi-asserted-by": "crossref",
      "first-page": "8573",
      "issue": "24",
      "journal-title": "Proc Natl Acad Sci U S A",
      "key": "109_CR17",
      "unstructured": "Johannessen CM, Reczek EE, James MF, Brems H, Legius E, Cichowski K. The NF1 tumor suppressor critically regulates TSC2 and mTOR. Proc Natl Acad Sci U S A. 2005;102(24):8573–8.",
      "volume": "102",
      "year": "2005"
    },
    {
      "DOI": "10.1146/annurev-neuro-060909-153215",
      "author": "C Shilyansky",
      "doi-asserted-by": "crossref",
      "first-page": "221",
      "journal-title": "Annu Rev Neurosci",
      "key": "109_CR18",
      "unstructured": "Shilyansky C, Lee YS, Silva AJ. Molecular and cellular mechanisms of learning disabilities: a focus on NF1. Annu Rev Neurosci. 2010;33:221–43.",
      "volume": "33",
      "year": "2010"
    },
    {
      "DOI": "10.1158/2159-8290.CD-13-0146",
      "author": "PE Hollstein",
      "doi-asserted-by": "crossref",
      "first-page": "880",
      "issue": "8",
      "journal-title": "Cancer Discov",
      "key": "109_CR19",
      "unstructured": "Hollstein PE, Cichowski K. Identifying the ubiquitin ligase complex that regulates the NF1 tumor suppressor and Ras. Cancer Discov. 2013;3(8):880–93.",
      "volume": "3",
      "year": "2013"
    },
    {
      "DOI": "10.1111/exd.13212",
      "doi-asserted-by": "publisher",
      "key": "109_CR20",
      "unstructured": "Peltonen S, Kallionpaa RA, Peltonen J. Neurofibromatosis type 1 (NF1) gene: beyond cafe au lait spots and dermal neurofibromas. Exp Dermatol. 2016. doi: 10.1111/exd.13212 ."
    },
    {
      "DOI": "10.1523/JNEUROSCI.3242-12.2012",
      "author": "DH Gutmann",
      "doi-asserted-by": "crossref",
      "first-page": "14087",
      "issue": "41",
      "journal-title": "J Neurosci",
      "key": "109_CR21",
      "unstructured": "Gutmann DH, Parada LF, Silva AJ, Ratner N. Neurofibromatosis type 1: modeling CNS dysfunction. J Neurosci. 2012;32(41):14087–93.",
      "volume": "32",
      "year": "2012"
    },
    {
      "key": "109_CR22",
      "unstructured": "Neurofibromin (NF1). https://grenada.lumc.nl/LOVD2/mendelian_genes/home.php?select_db=NF1 . Accessed Mar 2017."
    },
    {
      "DOI": "10.1007/s10689-006-9001-3",
      "author": "S Griffiths",
      "doi-asserted-by": "crossref",
      "first-page": "21",
      "issue": "1",
      "journal-title": "Fam Cancer",
      "key": "109_CR23",
      "unstructured": "Griffiths S, Thompson P, Frayling I, Upadhyaya M. Molecular diagnosis of neurofibromatosis type 1: 2 years experience. Fam Cancer. 2007;6(1):21–34.",
      "volume": "6",
      "year": "2007"
    },
    {
      "DOI": "10.1002/1098-1004(200006)15:6\u003c541::AID-HUMU6\u003e3.0.CO;2-N",
      "author": "LM Messiaen",
      "doi-asserted-by": "crossref",
      "first-page": "541",
      "issue": "6",
      "journal-title": "Hum Mutat",
      "key": "109_CR24",
      "unstructured": "Messiaen LM, Callens T, Mortier G, Beysen D, Vandenbroucke I, Van Roy N, Speleman F, Paepe AD. Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects. Hum Mutat. 2000;15(6):541–55.",
      "volume": "15",
      "year": "2000"
    },
    {
      "DOI": "10.1159/000126545",
      "doi-asserted-by": "crossref",
      "key": "109_CR25",
      "unstructured": "Messiaen LM, Wimmer K. NF1 Mutational spectrum. In: neurofibromatoses. Kaufmann D, editor. Basel: Karger; 2008:63–77."
    },
    {
      "DOI": "10.1111/cge.12187",
      "author": "R Minkelen van",
      "doi-asserted-by": "crossref",
      "first-page": "318",
      "issue": "4",
      "journal-title": "Clin Genet",
      "key": "109_CR26",
      "unstructured": "van Minkelen R, van Bever Y, Kromosoeto JN, Withagen-Hermans CJ, Nieuwlaat A, Halley DJ, van den Ouweland AM. A clinical and genetic overview of 18 years neurofibromatosis type 1 molecular diagnostics in the Netherlands. Clin Genet. 2014;85(4):318–27.",
      "volume": "85",
      "year": "2014"
    },
    {
      "DOI": "10.1007/s00439-017-1779-6",
      "author": "PD Stenson",
      "doi-asserted-by": "publisher",
      "journal-title": "Hum Genet",
      "key": "109_CR27",
      "unstructured": "Stenson PD, Mort M, Ball EV, Evans K, Hayden M, Heywood S, Hussain M, Phillips AD, Cooper DN. The Human Gene Mutation Database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies. Hum Genet. 2017. doi: 10.1007/s00439-017-1779-6 [Epub ahead of print].",
      "year": "2017"
    },
    {
      "DOI": "10.1016/j.ebiom.2016.04.005",
      "author": "DG Evans",
      "doi-asserted-by": "crossref",
      "first-page": "212",
      "journal-title": "EBioMedicine",
      "key": "109_CR28",
      "unstructured": "Evans DG, Bowers N, Burkitt-Wright E, Miles E, Garg S, Scott-Kitching V, Penman-Splitt M, Dobbie A, Howard E, Ealing J, et al. Comprehensive RNA analysis of the NF1 gene in classically affected NF1 affected individuals meeting NIH criteria has high sensitivity and mutation negative testing is reassuring in isolated cases with pigmentary features only. EBioMedicine. 2016;7:212–20.",
      "volume": "7",
      "year": "2016"
    },
    {
      "DOI": "10.1136/jmg.2009.075937",
      "author": "VF Mautner",
      "doi-asserted-by": "crossref",
      "first-page": "623",
      "issue": "9",
      "journal-title": "J Med Genet",
      "key": "109_CR29",
      "unstructured": "Mautner VF, Kluwe L, Friedrich RE, Roehl AC, Bammert S, Hogel J, Spori H, Cooper DN, Kehrer-Sawatzki H. Clinical characterisation of 29 neurofibromatosis type-1 patients with molecularly ascertained 1.4 Mb type-1 NF1 deletions. J Med Genet. 2010;47(9):623–30.",
      "volume": "47",
      "year": "2010"
    },
    {
      "DOI": "10.1002/humu.20826",
      "author": "E Pros",
      "doi-asserted-by": "crossref",
      "first-page": "E173",
      "issue": "9",
      "journal-title": "Hum Mutat",
      "key": "109_CR30",
      "unstructured": "Pros E, Gomez C, Martin T, Fabregas P, Serra E, Lazaro C. Nature and mRNA effect of 282 different NF1 point mutations: focus on splicing alterations. Hum Mutat. 2008;29(9):E173–193.",
      "volume": "29",
      "year": "2008"
    },
    {
      "author": "I Bottillo",
      "first-page": "1467",
      "issue": "6",
      "journal-title": "Am J Med Genet A",
      "key": "109_CR31",
      "unstructured": "Bottillo I, Torrente I, Lanari V, Pinna V, Giustini S, Divona L, De Luca A, Dallapiccola B. Germline mosaicism in neurofibromatosis type 1 due to a paternally derived multi-exon deletion. Am J Med Genet A. 2010;152A(6):1467–73.",
      "volume": "152A",
      "year": "2010"
    },
    {
      "author": "SD Colman",
      "first-page": "484",
      "issue": "3",
      "journal-title": "Am J Hum Genet",
      "key": "109_CR32",
      "unstructured": "Colman SD, Rasmussen SA, Ho VT, Abernathy CR, Wallace MR. Somatic mosaicism in a patient with neurofibromatosis type 1. Am J Hum Genet. 1996;58(3):484–90.",
      "volume": "58",
      "year": "1996"
    },
    {
      "DOI": "10.1056/NEJM199411243312102",
      "author": "C Lazaro",
      "doi-asserted-by": "crossref",
      "first-page": "1403",
      "issue": "21",
      "journal-title": "N Engl J Med",
      "key": "109_CR33",
      "unstructured": "Lazaro C, Ravella A, Gaona A, Volpini V, Estivill X. Neurofibromatosis type 1 due to germ-line mosaicism in a clinically normal father. N Engl J Med. 1994;331(21):1403–7.",
      "volume": "331",
      "year": "1994"
    },
    {
      "DOI": "10.1002/humu.21418",
      "author": "L Messiaen",
      "doi-asserted-by": "crossref",
      "first-page": "213",
      "issue": "2",
      "journal-title": "Hum Mutat",
      "key": "109_CR34",
      "unstructured": "Messiaen L, Vogt J, Bengesser K, Fu C, Mikhail F, Serra E, Garcia-Linares C, Cooper DN, Lazaro C, Kehrer-Sawatzki H. Mosaic type-1 NF1 microdeletions as a cause of both generalized and segmental neurofibromatosis type-1 (NF1). Hum Mutat. 2011;32(2):213–9.",
      "volume": "32",
      "year": "2011"
    },
    {
      "DOI": "10.1002/gcc.20289",
      "author": "K Wimmer",
      "doi-asserted-by": "crossref",
      "first-page": "265",
      "issue": "3",
      "journal-title": "Genes Chromosomes Cancer",
      "key": "109_CR35",
      "unstructured": "Wimmer K, Yao S, Claes K, Kehrer-Sawatzki H, Tinschert S, De Raedt T, Legius E, Callens T, Beiglbock H, Maertens O, et al. Spectrum of single- and multiexon NF1 copy number changes in a cohort of 1,100 unselected NF1 patients. Genes Chromosomes Cancer. 2006;45(3):265–76.",
      "volume": "45",
      "year": "2006"
    },
    {
      "DOI": "10.1002/humu.22162",
      "author": "L Thomas",
      "doi-asserted-by": "crossref",
      "first-page": "1687",
      "issue": "12",
      "journal-title": "Hum Mutat",
      "key": "109_CR36",
      "unstructured": "Thomas L, Richards M, Mort M, Dunlop E, Cooper DN, Upadhyaya M. Assessment of the potential pathogenicity of missense mutations identified in the GTPase-activating protein (GAP)-related domain of the neurofibromatosis type-1 (NF1) gene. Hum Mutat. 2012;33(12):1687–96.",
      "volume": "33",
      "year": "2012"
    },
    {
      "DOI": "10.1007/s10048-012-0332-y",
      "author": "H Kehrer-Sawatzki",
      "doi-asserted-by": "crossref",
      "first-page": "229",
      "issue": "3",
      "journal-title": "Neurogenetics",
      "key": "109_CR37",
      "unstructured": "Kehrer-Sawatzki H, Vogt J, Mussotter T, Kluwe L, Cooper DN, Mautner VF. Dissecting the clinical phenotype associated with mosaic type-2 NF1 microdeletions. Neurogenetics. 2012;13(3):229–36.",
      "volume": "13",
      "year": "2012"
    },
    {
      "DOI": "10.1517/17530059.2010.494660",
      "author": "M Upadhyaya",
      "doi-asserted-by": "crossref",
      "first-page": "307",
      "issue": "4",
      "journal-title": "Expert Opin Med Diagn",
      "key": "109_CR38",
      "unstructured": "Upadhyaya M. Neurofibromatosis type 1: diagnosis and recent advances. Expert Opin Med Diagn. 2010;4(4):307–22.",
      "volume": "4",
      "year": "2010"
    },
    {
      "DOI": "10.1093/hmg/ddw191",
      "author": "WE Tidyman",
      "doi-asserted-by": "crossref",
      "first-page": "R123",
      "issue": "R2",
      "journal-title": "Hum Mol Genet",
      "key": "109_CR39",
      "unstructured": "Tidyman WE, Rauen KA. Pathogenetics of the RASopathies. Hum Mol Genet. 2016;25(R2):R123–32.",
      "volume": "25",
      "year": "2016"
    },
    {
      "DOI": "10.1038/nature07943",
      "author": "MR Stratton",
      "doi-asserted-by": "crossref",
      "first-page": "719",
      "issue": "7239",
      "journal-title": "Nature",
      "key": "109_CR40",
      "unstructured": "Stratton MR, Campbell PJ, Futreal PA. The cancer genome. Nature. 2009;458(7239):719–24.",
      "volume": "458",
      "year": "2009"
    },
    {
      "key": "109_CR41",
      "unstructured": "The Cancer Genome Atlas (TCGA). http://cancergenome.nih.gov/ . Accessed Sept 2016."
    },
    {
      "key": "109_CR42",
      "unstructured": "International Cancer Genome Consortium (ICGC). http://icgc.org/ . Accessed Sept 2016."
    },
    {
      "key": "109_CR43",
      "unstructured": "Catalogue of Somatic Mutations in Cancer (COSMIC). http://cancer.sanger.ac.uk/cosmic . Accessed Sept 2016."
    },
    {
      "key": "109_CR44",
      "unstructured": "cBioPortal for Cancer Genomics. http://www.cbioportal.org/ . Accessed Sept 2016."
    },
    {
      "DOI": "10.1158/2159-8290.CD-12-0095",
      "author": "E Cerami",
      "doi-asserted-by": "crossref",
      "first-page": "401",
      "issue": "5",
      "journal-title": "Cancer Discov",
      "key": "109_CR45",
      "unstructured": "Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401–4.",
      "volume": "2",
      "year": "2012"
    },
    {
      "author": "J Gao",
      "first-page": "l1",
      "issue": "269",
      "journal-title": "Sci Signal",
      "key": "109_CR46",
      "unstructured": "Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6(269):l1.",
      "volume": "6",
      "year": "2013"
    },
    {
      "DOI": "10.1038/nrc3911",
      "author": "N Ratner",
      "doi-asserted-by": "crossref",
      "first-page": "290",
      "issue": "5",
      "journal-title": "Nat Rev Cancer",
      "key": "109_CR47",
      "unstructured": "Ratner N, Miller SJ. A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor. Nat Rev Cancer. 2015;15(5):290–301.",
      "volume": "15",
      "year": "2015"
    },
    {
      "DOI": "10.1038/ng0293-118",
      "author": "LB Andersen",
      "doi-asserted-by": "crossref",
      "first-page": "118",
      "issue": "2",
      "journal-title": "Nat Genet",
      "key": "109_CR48",
      "unstructured": "Andersen LB, Fountain JW, Gutmann DH, Tarle SA, Glover TW, Dracopoli NC, Housman DE, Collins FS. Mutations in the neurofibromatosis 1 gene in sporadic malignant melanoma cell lines. Nat Genet. 1993;3(2):118–21.",
      "volume": "3",
      "year": "1993"
    },
    {
      "DOI": "10.1038/ng.3361",
      "author": "M Krauthammer",
      "doi-asserted-by": "crossref",
      "first-page": "996",
      "issue": "9",
      "journal-title": "Nat Genet",
      "key": "109_CR49",
      "unstructured": "Krauthammer M, Kong Y, Bacchiocchi A, Evans P, Pornputtapong N, Wu C, McCusker JP, Ma S, Cheng E, Straub R, et al. Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomas. Nat Genet. 2015;47(9):996–1002.",
      "volume": "47",
      "year": "2015"
    },
    {
      "DOI": "10.1038/ng.2359",
      "author": "M Krauthammer",
      "doi-asserted-by": "crossref",
      "first-page": "1006",
      "issue": "9",
      "journal-title": "Nat Genet",
      "key": "109_CR50",
      "unstructured": "Krauthammer M, Kong Y, Ha BH, Evans P, Bacchiocchi A, McCusker JP, Cheng E, Davis MJ, Goh G, Choi M, et al. Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nat Genet. 2012;44(9):1006–14.",
      "volume": "44",
      "year": "2012"
    },
    {
      "DOI": "10.1016/j.cell.2012.06.024",
      "author": "E Hodis",
      "doi-asserted-by": "crossref",
      "first-page": "251",
      "issue": "2",
      "journal-title": "Cell",
      "key": "109_CR51",
      "unstructured": "Hodis E, Watson IR, Kryukov GV, Arold ST, Imielinski M, Theurillat JP, Nickerson E, Auclair D, Li L, Place C, et al. A landscape of driver mutations in melanoma. Cell. 2012;150(2):251–63.",
      "volume": "150",
      "year": "2012"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-13-2625",
      "author": "MH Nissan",
      "doi-asserted-by": "crossref",
      "first-page": "2340",
      "issue": "8",
      "journal-title": "Cancer Res",
      "key": "109_CR52",
      "unstructured": "Nissan MH, Pratilas CA, Jones AM, Ramirez R, Won H, Liu C, Tiwari S, Kong L, Hanrahan AJ, Yao Z, et al. Loss of NF1 in cutaneous melanoma is associated with RAS activation and MEK dependence. Cancer Res. 2014;74(8):2340–50.",
      "volume": "74",
      "year": "2014"
    },
    {
      "DOI": "10.1158/2159-8290.CD-12-0470",
      "author": "SR Whittaker",
      "doi-asserted-by": "crossref",
      "first-page": "350",
      "issue": "3",
      "journal-title": "Cancer Discov",
      "key": "109_CR53",
      "unstructured": "Whittaker SR, Theurillat JP, Van Allen E, Wagle N, Hsiao J, Cowley GS, Schadendorf D, Root DE, Garraway LA. A genome-scale RNA interference screen implicates NF1 loss in resistance to RAF inhibition. Cancer Discov. 2013;3(3):350–62.",
      "volume": "3",
      "year": "2013"
    },
    {
      "DOI": "10.1038/ncomms5852",
      "author": "R Akbani",
      "doi-asserted-by": "crossref",
      "first-page": "4852",
      "journal-title": "Nat Commun",
      "key": "109_CR54",
      "unstructured": "Akbani R, Ng PK, Werner HM, Shahmoradgoli M, Zhang F, Ju Z, Liu W, Yang JY, Yoshihara K, Li J, et al. Corrigendum: a pan-cancer proteomic perspective on The Cancer Genome Atlas. Nat Commun. 2015;6:4852.",
      "volume": "6",
      "year": "2015"
    },
    {
      "DOI": "10.1038/ncomms4887",
      "author": "R Akbani",
      "doi-asserted-by": "crossref",
      "first-page": "3887",
      "journal-title": "Nat Commun",
      "key": "109_CR55",
      "unstructured": "Akbani R, Ng PK, Werner HM, Shahmoradgoli M, Zhang F, Ju Z, Liu W, Yang JY, Yoshihara K, Li J, et al. A pan-cancer proteomic perspective on The Cancer Genome Atlas. Nat Commun. 2014;5:3887.",
      "volume": "5",
      "year": "2014"
    },
    {
      "DOI": "10.1146/annurev-genom-091212-153429",
      "author": "VK Hill",
      "doi-asserted-by": "crossref",
      "first-page": "257",
      "journal-title": "Annu Rev Genomics Hum Genet",
      "key": "109_CR56",
      "unstructured": "Hill VK, Gartner JJ, Samuels Y, Goldstein AM. The genetics of melanoma: recent advances. Annu Rev Genomics Hum Genet. 2013;14:257–79.",
      "volume": "14",
      "year": "2013"
    },
    {
      "DOI": "10.1016/j.ccr.2004.09.022",
      "author": "MJ Garnett",
      "doi-asserted-by": "crossref",
      "first-page": "313",
      "issue": "4",
      "journal-title": "Cancer Cell",
      "key": "109_CR57",
      "unstructured": "Garnett MJ, Marais R. Guilty as charged: B-RAF is a human oncogene. Cancer Cell. 2004;6(4):313–9.",
      "volume": "6",
      "year": "2004"
    },
    {
      "DOI": "10.1158/2159-8290.CD-12-0313",
      "author": "O Maertens",
      "doi-asserted-by": "crossref",
      "first-page": "338",
      "issue": "3",
      "journal-title": "Cancer Discov",
      "key": "109_CR58",
      "unstructured": "Maertens O, Johnson B, Hollstein P, Frederick DT, Cooper ZA, Messiaen L, Bronson RT, McMahon M, Granter S, Flaherty K, et al. Elucidating distinct roles for NF1 in melanomagenesis. Cancer Discov. 2013;3(3):338–49.",
      "volume": "3",
      "year": "2013"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-13-0398",
      "author": "VJ Mar",
      "doi-asserted-by": "crossref",
      "first-page": "4589",
      "issue": "17",
      "journal-title": "Clin Cancer Res",
      "key": "109_CR59",
      "unstructured": "Mar VJ, Wong SQ, Li J, Scolyer RA, McLean C, Papenfuss AT, Tothill RW, Kakavand H, Mann GJ, Thompson JF, et al. BRAF/NRAS wild-type melanomas have a high mutation load correlating with histologic and molecular signatures of UV damage. Clin Cancer Res. 2013;19(17):4589–98.",
      "volume": "19",
      "year": "2013"
    },
    {
      "DOI": "10.1097/PAS.0000000000000451",
      "author": "T Wiesner",
      "doi-asserted-by": "crossref",
      "first-page": "1357",
      "issue": "10",
      "journal-title": "Am J Surg Pathol",
      "key": "109_CR60",
      "unstructured": "Wiesner T, Kiuru M, Scott SN, Arcila M, Halpern AC, Hollmann T, Berger MF, Busam KJ. NF1 mutations are common in desmoplastic melanoma. Am J Surg Pathol. 2015;39(10):1357–62.",
      "volume": "39",
      "year": "2015"
    },
    {
      "DOI": "10.1056/NEJMoa1502583",
      "author": "AH Shain",
      "doi-asserted-by": "crossref",
      "first-page": "1926",
      "issue": "20",
      "journal-title": "N Engl J Med",
      "key": "109_CR61",
      "unstructured": "Shain AH, Yeh I, Kovalyshyn I, Sriharan A, Talevich E, Gagnon A, Dummer R, North J, Pincus L, Ruben B, et al. The genetic evolution of melanoma from precursor lesions. N Engl J Med. 2015;373(20):1926–36.",
      "volume": "373",
      "year": "2015"
    },
    {
      "DOI": "10.1001/archopht.121.9.1311",
      "author": "WJ Foster",
      "doi-asserted-by": "crossref",
      "first-page": "1311",
      "issue": "9",
      "journal-title": "Arch Ophthalmol",
      "key": "109_CR62",
      "unstructured": "Foster WJ, Fuller CE, Perry A, Harbour JW. Status of the NF1 tumor suppressor locus in uveal melanoma. Arch Ophthalmol. 2003;121(9):1311–5.",
      "volume": "121",
      "year": "2003"
    },
    {
      "DOI": "10.18632/oncotarget.16542",
      "doi-asserted-by": "crossref",
      "key": "109_CR63",
      "unstructured": "Cosgarea I, Ugurel S, Sucker A, Livingstone E, Zimmer L, Ziemer M, Utikal J, Mohr P, Pfeiffer C, Pfohler C, et al. Targeted next generation sequencing of mucosal melanomas identifies frequent NF1 and RAS mutations. Oncotarget. 2017."
    },
    {
      "key": "109_CR64",
      "unstructured": "Stewart B, Wild CP. World Cancer Report 2014. International Agency for Research on Cancer. Lyons: WHO Press; 2014."
    },
    {
      "DOI": "10.1038/nature07423",
      "author": "L Ding",
      "doi-asserted-by": "crossref",
      "first-page": "1069",
      "issue": "7216",
      "journal-title": "Nature",
      "key": "109_CR65",
      "unstructured": "Ding L, Getz G, Wheeler DA, Mardis ER, McLellan MD, Cibulskis K, Sougnez C, Greulich H, Muzny DM, Morgan MB, et al. Somatic mutations affect key pathways in lung adenocarcinoma. Nature. 2008;455(7216):1069–75.",
      "volume": "455",
      "year": "2008"
    },
    {
      "DOI": "10.1016/j.cell.2012.08.029",
      "author": "M Imielinski",
      "doi-asserted-by": "crossref",
      "first-page": "1107",
      "issue": "6",
      "journal-title": "Cell",
      "key": "109_CR66",
      "unstructured": "Imielinski M, Berger AH, Hammerman PS, Hernandez B, Pugh TJ, Hodis E, Cho J, Suh J, Capelletti M, Sivachenko A, et al. Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell. 2012;150(6):1107–20.",
      "volume": "150",
      "year": "2012"
    },
    {
      "DOI": "10.1038/nature13385",
      "author": "Cancer Genome Atlas Research N",
      "doi-asserted-by": "crossref",
      "first-page": "543",
      "issue": "7511",
      "journal-title": "Nature",
      "key": "109_CR67",
      "unstructured": "Cancer Genome Atlas Research N. Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014;511(7511):543–50.",
      "volume": "511",
      "year": "2014"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-15-2377",
      "author": "AJ Redig",
      "doi-asserted-by": "crossref",
      "first-page": "3148",
      "issue": "13",
      "journal-title": "Clin Cancer Res",
      "key": "109_CR68",
      "unstructured": "Redig AJ, Capelletti M, Dahlberg SE, Sholl LM, Mach S, Fontes C, Shi Y, Chalasani P, Janne PA. Clinical and molecular characteristics of NF1-mutant lung cancer. Clin Cancer Res. 2016;22(13):3148–56.",
      "volume": "22",
      "year": "2016"
    },
    {
      "DOI": "10.3322/caac.20107",
      "author": "A Jemal",
      "doi-asserted-by": "crossref",
      "first-page": "69",
      "issue": "2",
      "journal-title": "CA Cancer J Clin",
      "key": "109_CR69",
      "unstructured": "Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90.",
      "volume": "61",
      "year": "2011"
    },
    {
      "DOI": "10.1038/nm.2673",
      "author": "D Lipson",
      "doi-asserted-by": "crossref",
      "first-page": "382",
      "issue": "3",
      "journal-title": "Nat Med",
      "key": "109_CR70",
      "unstructured": "Lipson D, Capelletti M, Yelensky R, Otto G, Parker A, Jarosz M, Curran JA, Balasubramanian S, Bloom T, Brennan KW, et al. Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies. Nat Med. 2012;18(3):382–4.",
      "volume": "18",
      "year": "2012"
    },
    {
      "DOI": "10.1158/2159-8290.CD-13-0741",
      "author": "EC Bruin de",
      "doi-asserted-by": "crossref",
      "first-page": "606",
      "issue": "5",
      "journal-title": "Cancer Discov",
      "key": "109_CR71",
      "unstructured": "de Bruin EC, Cowell C, Warne PH, Jiang M, Saunders RE, Melnick MA, Gettinger S, Walther Z, Wurtz A, Heynen GJ, et al. Reduced NF1 expression confers resistance to EGFR inhibition in lung cancer. Cancer Discov. 2014;4(5):606–19.",
      "volume": "4",
      "year": "2014"
    },
    {
      "DOI": "10.1038/nature11404",
      "author": "Cancer Genome Atlas Research N",
      "doi-asserted-by": "crossref",
      "first-page": "519",
      "issue": "7417",
      "journal-title": "Nature",
      "key": "109_CR72",
      "unstructured": "Cancer Genome Atlas Research N. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012;489(7417):519–25.",
      "volume": "489",
      "year": "2012"
    },
    {
      "DOI": "10.1038/ncomms6893",
      "author": "SM Dhanasekaran",
      "doi-asserted-by": "crossref",
      "first-page": "5893",
      "journal-title": "Nat Commun",
      "key": "109_CR73",
      "unstructured": "Dhanasekaran SM, Balbin OA, Chen G, Nadal E, Kalyana-Sundaram S, Pan J, Veeneman B, Cao X, Malik R, Vats P, et al. Transcriptome meta-analysis of lung cancer reveals recurrent aberrations in NRG1 and Hippo pathway genes. Nat Commun. 2014;5:5893.",
      "volume": "5",
      "year": "2014"
    },
    {
      "DOI": "10.1038/ng.3564",
      "author": "JD Campbell",
      "doi-asserted-by": "crossref",
      "first-page": "607",
      "issue": "6",
      "journal-title": "Nat Genet",
      "key": "109_CR74",
      "unstructured": "Campbell JD, Alexandrov A, Kim J, Wala J, Berger AH, Pedamallu CS, Shukla SA, Guo G, Brooks AN, Murray BA, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016;48(6):607–16.",
      "volume": "48",
      "year": "2016"
    },
    {
      "DOI": "10.1016/S1470-2045(15)00077-7",
      "author": "S Devarakonda",
      "doi-asserted-by": "crossref",
      "first-page": "e342",
      "issue": "7",
      "journal-title": "Lancet Oncol",
      "key": "109_CR75",
      "unstructured": "Devarakonda S, Morgensztern D, Govindan R. Genomic alterations in lung adenocarcinoma. Lancet Oncol. 2015;16(7):e342–351.",
      "volume": "16",
      "year": "2015"
    },
    {
      "DOI": "10.1038/ng.2405",
      "author": "CM Rudin",
      "doi-asserted-by": "crossref",
      "first-page": "1111",
      "issue": "10",
      "journal-title": "Nat Genet",
      "key": "109_CR76",
      "unstructured": "Rudin CM, Durinck S, Stawiski EW, Poirier JT, Modrusan Z, Shames DS, Bergbower EA, Guan Y, Shin J, Guillory J, et al. Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer. Nat Genet. 2012;44(10):1111–6.",
      "volume": "44",
      "year": "2012"
    },
    {
      "DOI": "10.1038/ng.2396",
      "author": "M Peifer",
      "doi-asserted-by": "crossref",
      "first-page": "1104",
      "issue": "10",
      "journal-title": "Nat Genet",
      "key": "109_CR77",
      "unstructured": "Peifer M, Fernandez-Cuesta L, Sos ML, George J, Seidel D, Kasper LH, Plenker D, Leenders F, Sun R, Zander T, et al. Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Nat Genet. 2012;44(10):1104–10.",
      "volume": "44",
      "year": "2012"
    },
    {
      "DOI": "10.1136/jclinpath-2014-202447",
      "author": "JS Ross",
      "doi-asserted-by": "crossref",
      "first-page": "772",
      "issue": "9",
      "journal-title": "J Clin Pathol",
      "key": "109_CR78",
      "unstructured": "Ross JS, Wang K, Elkadi OR, Tarasen A, Foulke L, Sheehan CE, Otto GA, Palmer G, Yelensky R, Lipson D, et al. Next-generation sequencing reveals frequent consistent genomic alterations in small cell undifferentiated lung cancer. J Clin Pathol. 2014;67(9):772–6.",
      "volume": "67",
      "year": "2014"
    },
    {
      "DOI": "10.1182/blood-2007-06-095075",
      "author": "BV Balgobind",
      "doi-asserted-by": "crossref",
      "first-page": "4322",
      "issue": "8",
      "journal-title": "Blood",
      "key": "109_CR79",
      "unstructured": "Balgobind BV, Van Vlierberghe P, van den Ouweland AM, Beverloo HB, Terlouw-Kromosoeto JN, van Wering ER, Reinhardt D, Horstmann M, Kaspers GJ, Pieters R, et al. Leukemia-associated NF1 inactivation in patients with pediatric T-ALL and AML lacking evidence for neurofibromatosis. Blood. 2008;111(8):4322–8.",
      "volume": "111",
      "year": "2008"
    },
    {
      "DOI": "10.1182/blood.V94.1.225.413k24_225_232",
      "author": "T Fioretos",
      "doi-asserted-by": "crossref",
      "first-page": "225",
      "issue": "1",
      "journal-title": "Blood",
      "key": "109_CR80",
      "unstructured": "Fioretos T, Strombeck B, Sandberg T, Johansson B, Billstrom R, Borg A, Nilsson PG, Van Den Berghe H, Hagemeijer A, Mitelman F, et al. Isochromosome 17q in blast crisis of chronic myeloid leukemia and in other hematologic malignancies is the result of clustered breakpoints in 17p11 and is not associated with coding TP53 mutations. Blood. 1999;94(1):225–32.",
      "volume": "94",
      "year": "1999"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-07-1005",
      "author": "BS Braun",
      "doi-asserted-by": "crossref",
      "first-page": "2249",
      "issue": "8",
      "journal-title": "Clin Cancer Res",
      "key": "109_CR81",
      "unstructured": "Braun BS, Shannon K. Targeting Ras in myeloid leukemias. Clin Cancer Res. 2008;14(8):2249–52.",
      "volume": "14",
      "year": "2008"
    },
    {
      "DOI": "10.1002/ajh.23403",
      "author": "E Boudry-Labis",
      "doi-asserted-by": "crossref",
      "first-page": "306",
      "issue": "4",
      "journal-title": "Am J Hematol",
      "key": "109_CR82",
      "unstructured": "Boudry-Labis E, Roche-Lestienne C, Nibourel O, Boissel N, Terre C, Perot C, Eclache V, Gachard N, Tigaud I, Plessis G, et al. Neurofibromatosis-1 gene deletions and mutations in de novo adult acute myeloid leukemia. Am J Hematol. 2013;88(4):306–11.",
      "volume": "88",
      "year": "2013"
    },
    {
      "DOI": "10.1371/journal.pone.0047717",
      "author": "L Garcia-Orti",
      "doi-asserted-by": "crossref",
      "first-page": "e47717",
      "issue": "10",
      "journal-title": "PLoS One",
      "key": "109_CR83",
      "unstructured": "Garcia-Orti L, Cristobal I, Cirauqui C, Guruceaga E, Marcotegui N, Calasanz MJ, Castello-Cros R, Odero MD. Integration of SNP and mRNA arrays with microRNA profiling reveals that MiR-370 is upregulated and targets NF1 in acute myeloid leukemia. PLoS One. 2012;7(10):e47717.",
      "volume": "7",
      "year": "2012"
    },
    {
      "DOI": "10.1038/leu.2011.296",
      "author": "C Haferlach",
      "doi-asserted-by": "crossref",
      "first-page": "834",
      "issue": "4",
      "journal-title": "Leukemia",
      "key": "109_CR84",
      "unstructured": "Haferlach C, Grossmann V, Kohlmann A, Schindela S, Kern W, Schnittger S, Haferlach T. Deletion of the tumor-suppressor gene NF1 occurs in 5% of myeloid malignancies and is accompanied by a mutation in the remaining allele in half of the cases. Leukemia. 2012;26(4):834–9.",
      "volume": "26",
      "year": "2012"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-09-2639",
      "author": "B Parkin",
      "doi-asserted-by": "crossref",
      "first-page": "4135",
      "issue": "16",
      "journal-title": "Clin Cancer Res",
      "key": "109_CR85",
      "unstructured": "Parkin B, Ouillette P, Wang Y, Liu Y, Wright W, Roulston D, Purkayastha A, Dressel A, Karp J, Bockenstedt P, et al. NF1 inactivation in adult acute myelogenous leukemia. Clin Cancer Res. 2010;16(16):4135–47.",
      "volume": "16",
      "year": "2010"
    },
    {
      "author": "S Misawa",
      "first-page": "533",
      "issue": "Suppl 3",
      "journal-title": "Leukemia",
      "key": "109_CR86",
      "unstructured": "Misawa S, Horiike S, Kaneko H, Kashima K. Genetic aberrations in the development and subsequent progression of myelodysplastic syndrome. Leukemia. 1997;11 Suppl 3:533–5.",
      "volume": "11",
      "year": "1997"
    },
    {
      "DOI": "10.1016/j.cancergen.2011.10.004",
      "author": "KA Kolquist",
      "doi-asserted-by": "crossref",
      "first-page": "603",
      "issue": "11",
      "journal-title": "Cancer Genet",
      "key": "109_CR87",
      "unstructured": "Kolquist KA, Schultz RA, Furrow A, Brown TC, Han JY, Campbell LJ, Wall M, Slovak ML, Shaffer LG, Ballif BC. Microarray-based comparative genomic hybridization of cancer targets reveals novel, recurrent genetic aberrations in the myelodysplastic syndromes. Cancer Genet. 2011;204(11):603–28.",
      "volume": "204",
      "year": "2011"
    },
    {
      "DOI": "10.1371/journal.pone.0038463",
      "author": "Z Kalender Atak",
      "doi-asserted-by": "crossref",
      "first-page": "e38463",
      "issue": "6",
      "journal-title": "PLoS One",
      "key": "109_CR88",
      "unstructured": "Kalender Atak Z, De Keersmaecker K, Gianfelici V, Geerdens E, Vandepoel R, Pauwels D, Porcu M, Lahortiga I, Brys V, Dirks WG, et al. High accuracy mutation detection in leukemia on a selected panel of cancer genes. PLoS One. 2012;7(6):e38463.",
      "volume": "7",
      "year": "2012"
    },
    {
      "DOI": "10.1056/NEJM199706123362404",
      "author": "L Side",
      "doi-asserted-by": "crossref",
      "first-page": "1713",
      "issue": "24",
      "journal-title": "N Engl J Med",
      "key": "109_CR89",
      "unstructured": "Side L, Taylor B, Cayouette M, Conner E, Thompson P, Luce M, Shannon K. Homozygous inactivation of the NF1 gene in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disorders. N Engl J Med. 1997;336(24):1713–20.",
      "volume": "336",
      "year": "1997"
    },
    {
      "DOI": "10.1038/ng.3420",
      "author": "A Caye",
      "doi-asserted-by": "crossref",
      "first-page": "1334",
      "issue": "11",
      "journal-title": "Nat Genet",
      "key": "109_CR90",
      "unstructured": "Caye A, Strullu M, Guidez F, Cassinat B, Gazal S, Fenneteau O, Lainey E, Nouri K, Nakhaei-Rad S, Dvorsky R, et al. Juvenile myelomonocytic leukemia displays mutations in components of the RAS pathway and the PRC2 network. Nat Genet. 2015;47(11):1334–40.",
      "volume": "47",
      "year": "2015"
    },
    {
      "DOI": "10.1038/nature09784",
      "author": "R Margueron",
      "doi-asserted-by": "crossref",
      "first-page": "343",
      "issue": "7330",
      "journal-title": "Nature",
      "key": "109_CR91",
      "unstructured": "Margueron R, Reinberg D. The Polycomb complex PRC2 and its mark in life. Nature. 2011;469(7330):343–9.",
      "volume": "469",
      "year": "2011"
    },
    {
      "DOI": "10.1182/blood-2009-02-205146",
      "author": "BA Cutts",
      "doi-asserted-by": "crossref",
      "first-page": "3629",
      "issue": "17",
      "journal-title": "Blood",
      "key": "109_CR92",
      "unstructured": "Cutts BA, Sjogren AK, Andersson KM, Wahlstrom AM, Karlsson C, Swolin B, Bergo MO. Nf1 deficiency cooperates with oncogenic K-RAS to induce acute myeloid leukemia in mice. Blood. 2009;114(17):3629–32.",
      "volume": "114",
      "year": "2009"
    },
    {
      "DOI": "10.1016/j.hoc.2012.07.006",
      "author": "O Abdel-Wahab",
      "doi-asserted-by": "crossref",
      "first-page": "1053",
      "issue": "5",
      "journal-title": "Hematol Oncol Clin North Am",
      "key": "109_CR93",
      "unstructured": "Abdel-Wahab O, Tefferi A, Levine RL. Role of TET2 and ASXL1 mutations in the pathogenesis of myeloproliferative neoplasms. Hematol Oncol Clin North Am. 2012;26(5):1053–64.",
      "volume": "26",
      "year": "2012"
    },
    {
      "DOI": "10.1038/leu.2012.288",
      "author": "O Abdel-Wahab",
      "doi-asserted-by": "crossref",
      "first-page": "10",
      "issue": "1",
      "journal-title": "Leukemia",
      "key": "109_CR94",
      "unstructured": "Abdel-Wahab O, Dey A. The ASXL-BAP1 axis: new factors in myelopoiesis, cancer and epigenetics. Leukemia. 2013;27(1):10–5.",
      "volume": "27",
      "year": "2013"
    },
    {
      "DOI": "10.1038/nature13561",
      "author": "T Raedt De",
      "doi-asserted-by": "crossref",
      "first-page": "247",
      "issue": "7521",
      "journal-title": "Nature",
      "key": "109_CR95",
      "unstructured": "De Raedt T, Beert E, Pasmant E, Luscan A, Brems H, Ortonne N, Helin K, Hornick JL, Mautner V, Kehrer-Sawatzki H, et al. PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapies. Nature. 2014;514(7521):247–51.",
      "volume": "514",
      "year": "2014"
    },
    {
      "DOI": "10.1038/ng.3095",
      "author": "W Lee",
      "doi-asserted-by": "crossref",
      "first-page": "1227",
      "issue": "11",
      "journal-title": "Nat Genet",
      "key": "109_CR96",
      "unstructured": "Lee W, Teckie S, Wiesner T, Ran L, Prieto Granada CN, Lin M, Zhu S, Cao Z, Liang Y, Sboner A, et al. PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors. Nat Genet. 2014;46(11):1227–32.",
      "volume": "46",
      "year": "2014"
    },
    {
      "DOI": "10.1038/ng.3400",
      "author": "E Stieglitz",
      "doi-asserted-by": "crossref",
      "first-page": "1326",
      "issue": "11",
      "journal-title": "Nat Genet",
      "key": "109_CR97",
      "unstructured": "Stieglitz E, Taylor-Weiner AN, Chang TY, Gelston LC, Wang YD, Mazor T, Esquivel E, Yu A, Seepo S, Olsen SR, et al. The genomic landscape of juvenile myelomonocytic leukemia. Nat Genet. 2015;47(11):1326–33.",
      "volume": "47",
      "year": "2015"
    },
    {
      "DOI": "10.1136/jmg.2007.049346",
      "author": "S Sharif",
      "doi-asserted-by": "crossref",
      "first-page": "481",
      "issue": "8",
      "journal-title": "J Med Genet",
      "key": "109_CR98",
      "unstructured": "Sharif S, Moran A, Huson SM, Iddenden R, Shenton A, Howard E, Evans DG. Women with neurofibromatosis 1 are at a moderately increased risk of developing breast cancer and should be considered for early screening. J Med Genet. 2007;44(8):481–4.",
      "volume": "44",
      "year": "2007"
    },
    {
      "DOI": "10.1038/ejhg.2011.113",
      "author": "DG Evans",
      "doi-asserted-by": "crossref",
      "first-page": "1187",
      "issue": "11",
      "journal-title": "Eur J Hum Genet",
      "key": "109_CR99",
      "unstructured": "Evans DG, O’Hara C, Wilding A, Ingham SL, Howard E, Dawson J, Moran A, Scott-Kitching V, Holt F, Huson SM. Mortality in neurofibromatosis 1: in North West England: an assessment of actuarial survival in a region of the UK since 1989. Eur J Hum Genet. 2011;19(11):1187–91.",
      "volume": "19",
      "year": "2011"
    },
    {
      "DOI": "10.1002/ajmg.a.35550",
      "author": "SA Madanikia",
      "doi-asserted-by": "crossref",
      "first-page": "3056",
      "issue": "12",
      "journal-title": "Am J Med Genet A",
      "key": "109_CR100",
      "unstructured": "Madanikia SA, Bergner A, Ye X, Blakeley JO. Increased risk of breast cancer in women with NF1. Am J Med Genet A. 2012;158A(12):3056–60.",
      "volume": "158A",
      "year": "2012"
    },
    {
      "DOI": "10.1126/science.1133427",
      "author": "T Sjoblom",
      "doi-asserted-by": "crossref",
      "first-page": "268",
      "issue": "5797",
      "journal-title": "Science",
      "key": "109_CR101",
      "unstructured": "Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N, et al. The consensus coding sequences of human breast and colorectal cancers. Science. 2006;314(5797):268–74.",
      "volume": "314",
      "year": "2006"
    },
    {
      "DOI": "10.1038/nature11017",
      "author": "PJ Stephens",
      "doi-asserted-by": "crossref",
      "first-page": "400",
      "issue": "7403",
      "journal-title": "Nature",
      "key": "109_CR102",
      "unstructured": "Stephens PJ, Tarpey PS, Davies H, Van Loo P, Greenman C, Wedge DC, Nik-Zainal S, Martin S, Varela I, Bignell GR, et al. The landscape of cancer genes and mutational processes in breast cancer. Nature. 2012;486(7403):400–4.",
      "volume": "486",
      "year": "2012"
    },
    {
      "DOI": "10.1016/S0304-3835(01)00648-6",
      "author": "H Ogata",
      "doi-asserted-by": "crossref",
      "first-page": "159",
      "issue": "2",
      "journal-title": "Cancer Lett",
      "key": "109_CR103",
      "unstructured": "Ogata H, Sato H, Takatsuka J, De Luca LM. Human breast cancer MDA-MB-231 cells fail to express the neurofibromin protein, lack its type I mRNA isoform and show accumulation of P-MAPK and activated Ras. Cancer Lett. 2001;172(2):159–64.",
      "volume": "172",
      "year": "2001"
    },
    {
      "DOI": "10.1038/ng1936",
      "author": "N Shima",
      "doi-asserted-by": "crossref",
      "first-page": "93",
      "issue": "1",
      "journal-title": "Nat Genet",
      "key": "109_CR104",
      "unstructured": "Shima N, Alcaraz A, Liachko I, Buske TR, Andrews CA, Munroe RJ, Hartford SA, Tye BK, Schimenti JC. A viable allele of Mcm4 causes chromosome instability and mammary adenocarcinomas in mice. Nat Genet. 2007;39(1):93–8.",
      "volume": "39",
      "year": "2007"
    },
    {
      "DOI": "10.1534/genetics.112.142802",
      "author": "MD Wallace",
      "doi-asserted-by": "crossref",
      "first-page": "385",
      "issue": "2",
      "journal-title": "Genetics",
      "key": "109_CR105",
      "unstructured": "Wallace MD, Pfefferle AD, Shen L, McNairn AJ, Cerami EG, Fallon BL, Rinaldi VD, Southard TL, Perou CM, Schimenti JC. Comparative oncogenomics implicates the neurofibromin 1 gene (NF1) as a breast cancer driver. Genetics. 2012;192(2):385–96.",
      "volume": "192",
      "year": "2012"
    },
    {
      "DOI": "10.1038/nature11412",
      "author": "Cancer Genome Atlas N",
      "doi-asserted-by": "crossref",
      "first-page": "61",
      "issue": "7418",
      "journal-title": "Nature",
      "key": "109_CR106",
      "unstructured": "Cancer Genome Atlas N. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61–70.",
      "volume": "490",
      "year": "2012"
    },
    {
      "DOI": "10.1158/1535-7163.MCT-13-0482",
      "author": "F Meric-Bernstam",
      "doi-asserted-by": "crossref",
      "first-page": "1382",
      "issue": "5",
      "journal-title": "Mol Cancer Ther",
      "key": "109_CR107",
      "unstructured": "Meric-Bernstam F, Frampton GM, Ferrer-Lozano J, Yelensky R, Perez-Fidalgo JA, Wang Y, Palmer GA, Ross JS, Miller VA, Su X, et al. Concordance of genomic alterations between primary and recurrent breast cancer. Mol Cancer Ther. 2014;13(5):1382–9.",
      "volume": "13",
      "year": "2014"
    },
    {
      "DOI": "10.1038/ncomms11908",
      "author": "B Pereira",
      "doi-asserted-by": "crossref",
      "first-page": "11908",
      "journal-title": "Nat Commun",
      "key": "109_CR108",
      "unstructured": "Pereira B, Chin SF, Rueda OM, Vollan HK, Provenzano E, Bardwell HA, Pugh M, Jones L, Russell R, Sammut SJ, et al. Erratum: the somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes. Nat Commun. 2016;7:11908.",
      "volume": "7",
      "year": "2016"
    },
    {
      "DOI": "10.1038/ncomms11479",
      "author": "B Pereira",
      "doi-asserted-by": "crossref",
      "first-page": "11479",
      "journal-title": "Nat Commun",
      "key": "109_CR109",
      "unstructured": "Pereira B, Chin SF, Rueda OM, Vollan HK, Provenzano E, Bardwell HA, Pugh M, Jones L, Russell R, Sammut SJ, et al. The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes. Nat Commun. 2016;7:11479.",
      "volume": "7",
      "year": "2016"
    },
    {
      "author": "XY Cui",
      "first-page": "1813",
      "issue": "10",
      "journal-title": "Nan Fang Yi Ke Da Xue Xue Bao",
      "key": "109_CR110",
      "unstructured": "Cui XY, Guo YJ, Yao HR. Analysis of microRNA in drug-resistant breast cancer cell line MCF-7/ADR. Nan Fang Yi Ke Da Xue Xue Bao. 2008;28(10):1813–5.",
      "volume": "28",
      "year": "2008"
    },
    {
      "DOI": "10.1073/pnas.1018872108",
      "author": "AM Mendes-Pereira",
      "doi-asserted-by": "crossref",
      "first-page": "2730",
      "issue": "8",
      "journal-title": "Proc Natl Acad Sci U S A",
      "key": "109_CR111",
      "unstructured": "Mendes-Pereira AM, Sims D, Dexter T, Fenwick K, Assiotis I, Kozarewa I, Mitsopoulos C, Hakas J, Zvelebil M, Lord CJ, et al. Genome-wide functional screen identifies a compendium of genes affecting sensitivity to tamoxifen. Proc Natl Acad Sci U S A. 2012;109(8):2730–5.",
      "volume": "109",
      "year": "2012"
    },
    {
      "DOI": "10.1677/erc.1.00776",
      "author": "A Ring",
      "doi-asserted-by": "crossref",
      "first-page": "643",
      "issue": "4",
      "journal-title": "Endocr Relat Cancer",
      "key": "109_CR112",
      "unstructured": "Ring A, Dowsett M. Mechanisms of tamoxifen resistance. Endocr Relat Cancer. 2004;11(4):643–58.",
      "volume": "11",
      "year": "2004"
    },
    {
      "DOI": "10.1593/neo.08784",
      "author": "N Sangha",
      "doi-asserted-by": "crossref",
      "first-page": "1362",
      "issue": "12",
      "journal-title": "Neoplasia",
      "key": "109_CR113",
      "unstructured": "Sangha N, Wu R, Kuick R, Powers S, Mu D, Fiander D, Yuen K, Katabuchi H, Tashiro H, Fearon ER, et al. Neurofibromin 1 (NF1) defects are common in human ovarian serous carcinomas and co-occur with TP53 mutations. Neoplasia. 2008;10(12):1362–72. following 1372.",
      "volume": "10",
      "year": "2008"
    },
    {
      "DOI": "10.1016/S0020-7292(06)60033-7",
      "author": "AP Heintz",
      "doi-asserted-by": "crossref",
      "first-page": "S161",
      "journal-title": "Int J Gynaecol Obstet",
      "key": "109_CR114",
      "unstructured": "Heintz AP, Odicino F, Maisonneuve P, Quinn MA, Benedet JL, Creasman WT, Ngan HY, Pecorelli S, Beller U. Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006;95 Suppl 1:S161–192.",
      "volume": "95 Suppl 1",
      "year": "2006"
    },
    {
      "DOI": "10.1371/journal.pone.0011408",
      "doi-asserted-by": "crossref",
      "key": "109_CR115",
      "unstructured": "Gorringe KL, George J, Anglesio MS, Ramakrishna M, Etemadmoghadam D, Cowin P, Sridhar A, Williams LH, Boyle SE, Yanaihara N, et al. Copy number analysis identifies novel interactions between genomic loci in ovarian cancer. PLoS One. 2010;5(9):e11408."
    },
    {
      "DOI": "10.1038/onc.2010.245",
      "author": "SL Cooke",
      "doi-asserted-by": "crossref",
      "first-page": "4905",
      "issue": "35",
      "journal-title": "Oncogene",
      "key": "109_CR116",
      "unstructured": "Cooke SL, Ng CK, Melnyk N, Garcia MJ, Hardcastle T, Temple J, Langdon S, Huntsman D, Brenton JD. Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma. Oncogene. 2010;29(35):4905–13.",
      "volume": "29",
      "year": "2010"
    },
    {
      "DOI": "10.1007/s11912-016-0526-9",
      "author": "L Mittempergher",
      "doi-asserted-by": "crossref",
      "first-page": "44",
      "issue": "7",
      "journal-title": "Curr Oncol Rep",
      "key": "109_CR117",
      "unstructured": "Mittempergher L. Genomic characterization of high-grade serous ovarian cancer: dissecting its molecular heterogeneity as a road towards effective therapeutic strategies. Curr Oncol Rep. 2016;18(7):44.",
      "volume": "18",
      "year": "2016"
    },
    {
      "DOI": "10.1016/j.canlet.2013.06.014",
      "author": "K Kulkarni-Datar",
      "doi-asserted-by": "crossref",
      "first-page": "237",
      "issue": "2",
      "journal-title": "Cancer Lett",
      "key": "109_CR118",
      "unstructured": "Kulkarni-Datar K, Orsulic S, Foster R, Rueda BR. Ovarian tumor initiating cell populations persist following paclitaxel and carboplatin chemotherapy treatment in vivo. Cancer Lett. 2013;339(2):237–46.",
      "volume": "339",
      "year": "2013"
    },
    {
      "author": "CA Koch",
      "first-page": "43",
      "issue": "1",
      "journal-title": "Endocr Regul",
      "key": "109_CR119",
      "unstructured": "Koch CA, Vortmeyer AO, Huang SC, Alesci S, Zhuang Z, Pacak K. Genetic aspects of pheochromocytoma. Endocr Regul. 2001;35(1):43–52.",
      "volume": "35",
      "year": "2001"
    },
    {
      "DOI": "10.1016/S0022-5347(05)68171-2",
      "author": "MM Walther",
      "doi-asserted-by": "crossref",
      "first-page": "1582",
      "issue": "5",
      "journal-title": "J Urol",
      "key": "109_CR120",
      "unstructured": "Walther MM, Herring J, Enquist E, Keiser HR, Linehan WM. von Recklinghausen’s disease and pheochromocytomas. J Urol. 1999;162(5):1582–6.",
      "volume": "162",
      "year": "1999"
    },
    {
      "DOI": "10.1093/hmg/dds402",
      "author": "J Welander",
      "doi-asserted-by": "crossref",
      "first-page": "5406",
      "issue": "26",
      "journal-title": "Hum Mol Genet",
      "key": "109_CR121",
      "unstructured": "Welander J, Larsson C, Backdahl M, Hareni N, Sivler T, Brauckhoff M, Soderkvist P, Gimm O. Integrative genomics reveals frequent somatic NF1 mutations in sporadic pheochromocytomas. Hum Mol Genet. 2012;21(26):5406–16.",
      "volume": "21",
      "year": "2012"
    },
    {
      "DOI": "10.1016/j.beem.2010.05.001",
      "author": "G Opocher",
      "doi-asserted-by": "crossref",
      "first-page": "943",
      "issue": "6",
      "journal-title": "Best Pract Res Clin Endocrinol Metab",
      "key": "109_CR122",
      "unstructured": "Opocher G, Schiavi F. Genetics of pheochromocytomas and paragangliomas. Best Pract Res Clin Endocrinol Metab. 2010;24(6):943–56.",
      "volume": "24",
      "year": "2010"
    },
    {
      "DOI": "10.1530/ERC-13-0046",
      "author": "J Welander",
      "doi-asserted-by": "crossref",
      "first-page": "C13",
      "issue": "4",
      "journal-title": "Endocr Relat Cancer",
      "key": "109_CR123",
      "unstructured": "Welander J, Soderkvist P, Gimm O. The NF1 gene: a frequent mutational target in sporadic pheochromocytomas and beyond. Endocr Relat Cancer. 2013;20(4):C13–17.",
      "volume": "20",
      "year": "2013"
    },
    {
      "DOI": "10.1093/hmg/dds374",
      "author": "N Burnichon",
      "doi-asserted-by": "crossref",
      "first-page": "5397",
      "issue": "26",
      "journal-title": "Hum Mol Genet",
      "key": "109_CR124",
      "unstructured": "Burnichon N, Buffet A, Parfait B, Letouze E, Laurendeau I, Loriot C, Pasmant E, Abermil N, Valeyrie-Allanore L, Bertherat J, et al. Somatic NF1 inactivation is a frequent event in sporadic pheochromocytoma. Hum Mol Genet. 2012;21(26):5397–405.",
      "volume": "21",
      "year": "2012"
    },
    {
      "DOI": "10.1016/j.cancergen.2012.01.009",
      "author": "L Fishbein",
      "doi-asserted-by": "crossref",
      "first-page": "1",
      "issue": "1-2",
      "journal-title": "Cancer Genet",
      "key": "109_CR125",
      "unstructured": "Fishbein L, Nathanson KL. Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background. Cancer Genet. 2012;205(1-2):1–11.",
      "volume": "205",
      "year": "2012"
    },
    {
      "DOI": "10.1111/cen.12071",
      "author": "SR Galan",
      "doi-asserted-by": "crossref",
      "first-page": "165",
      "issue": "2",
      "journal-title": "Clin Endocrinol (Oxf)",
      "key": "109_CR126",
      "unstructured": "Galan SR, Kann PH. Genetics and molecular pathogenesis of pheochromocytoma and paraganglioma. Clin Endocrinol (Oxf). 2013;78(2):165–75.",
      "volume": "78",
      "year": "2013"
    },
    {
      "DOI": "10.1016/j.cancergen.2011.03.001",
      "author": "RJ Deyell",
      "doi-asserted-by": "crossref",
      "first-page": "113",
      "issue": "3",
      "journal-title": "Cancer Genet",
      "key": "109_CR127",
      "unstructured": "Deyell RJ, Attiyeh EF. Advances in the understanding of constitutional and somatic genomic alterations in neuroblastoma. Cancer Genet. 2011;204(3):113–21.",
      "volume": "204",
      "year": "2011"
    },
    {
      "DOI": "10.1002/pbc.10381",
      "author": "T Shojaei-Brosseau",
      "doi-asserted-by": "crossref",
      "first-page": "99",
      "issue": "1",
      "journal-title": "Pediatr Blood Cancer",
      "key": "109_CR128",
      "unstructured": "Shojaei-Brosseau T, Chompret A, Abel A, de Vathaire F, Raquin MA, Brugieres L, Feunteun J, Hartmann O, Bonaiti-Pellie C. Genetic epidemiology of neuroblastoma: a study of 426 cases at the Institut Gustave-Roussy in France. Pediatr Blood Cancer. 2004;42(1):99–105.",
      "volume": "42",
      "year": "2004"
    },
    {
      "DOI": "10.1038/ng0193-62",
      "author": "AE Murthy",
      "doi-asserted-by": "crossref",
      "first-page": "62",
      "issue": "1",
      "journal-title": "Nat Genet",
      "key": "109_CR129",
      "unstructured": "The I, Murthy AE, Hannigan GE, Jacoby LB, Menon AG, Gusella JF, Bernards A. Neurofibromatosis type 1 gene mutations in neuroblastoma. Nat Genet. 1993;3(1):62–6.",
      "volume": "3",
      "year": "1993"
    },
    {
      "DOI": "10.1016/j.cell.2010.06.004",
      "author": "M Holzel",
      "doi-asserted-by": "crossref",
      "first-page": "218",
      "issue": "2",
      "journal-title": "Cell",
      "key": "109_CR130",
      "unstructured": "Holzel M, Huang S, Koster J, Ora I, Lakeman A, Caron H, Nijkamp W, Xie J, Callens T, Asgharzadeh S, et al. NF1 is a tumor suppressor in neuroblastoma that determines retinoic acid response and disease outcome. Cell. 2010;142(2):218–29.",
      "volume": "142",
      "year": "2010"
    },
    {
      "DOI": "10.1177/1947601912443127",
      "author": "D Han",
      "doi-asserted-by": "crossref",
      "first-page": "1034",
      "issue": "11",
      "journal-title": "Genes Cancer",
      "key": "109_CR131",
      "unstructured": "Han D, Spengler BA, Ross RA. Increased wild-type N-ras activation by neurofibromin down-regulation increases human neuroblastoma stem cell malignancy. Genes Cancer. 2011;2(11):1034–43.",
      "volume": "2",
      "year": "2011"
    },
    {
      "DOI": "10.1126/science.1164382",
      "author": "DW Parsons",
      "doi-asserted-by": "crossref",
      "first-page": "1807",
      "issue": "5897",
      "journal-title": "Science",
      "key": "109_CR132",
      "unstructured": "Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Siu IM, Gallia GL, et al. An integrated genomic analysis of human glioblastoma multiforme. Science. 2008;321(5897):1807–12.",
      "volume": "321",
      "year": "2008"
    },
    {
      "DOI": "10.1146/annurev.pathol.1.110304.100043",
      "author": "DN Louis",
      "doi-asserted-by": "crossref",
      "first-page": "97",
      "journal-title": "Annu Rev Pathol",
      "key": "109_CR133",
      "unstructured": "Louis DN. Molecular pathology of malignant gliomas. Annu Rev Pathol. 2006;1:97–117.",
      "volume": "1",
      "year": "2006"
    },
    {
      "DOI": "10.1016/j.cell.2013.09.034",
      "author": "CW Brennan",
      "doi-asserted-by": "crossref",
      "first-page": "462",
      "issue": "2",
      "journal-title": "Cell",
      "key": "109_CR134",
      "unstructured": "Brennan CW, Verhaak RG, McKenna A, Campos B, Noushmehr H, Salama SR, Zheng S, Chakravarty D, Sanborn JZ, Berman SH, et al. The somatic genomic landscape of glioblastoma. Cell. 2013;155(2):462–77.",
      "volume": "155",
      "year": "2013"
    },
    {
      "DOI": "10.1038/ng.2682",
      "author": "DT Jones",
      "doi-asserted-by": "crossref",
      "first-page": "927",
      "issue": "8",
      "journal-title": "Nat Genet",
      "key": "109_CR135",
      "unstructured": "Jones DT, Hutter B, Jager N, Korshunov A, Kool M, Warnatz HJ, Zichner T, Lambert SR, Ryzhova M, Quang DA, et al. Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma. Nat Genet. 2013;45(8):927–32.",
      "volume": "45",
      "year": "2013"
    },
    {
      "DOI": "10.1016/j.ccr.2009.12.020",
      "author": "RG Verhaak",
      "doi-asserted-by": "crossref",
      "first-page": "98",
      "issue": "1",
      "journal-title": "Cancer Cell",
      "key": "109_CR136",
      "unstructured": "Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010;17(1):98–110.",
      "volume": "17",
      "year": "2010"
    },
    {
      "DOI": "10.1016/j.ccr.2005.07.004",
      "author": "Y Zhu",
      "doi-asserted-by": "crossref",
      "first-page": "119",
      "issue": "2",
      "journal-title": "Cancer Cell",
      "key": "109_CR137",
      "unstructured": "Zhu Y, Guignard F, Zhao D, Liu L, Burns DK, Mason RP, Messing A, Parada LF. Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma. Cancer Cell. 2005;8(2):119–30.",
      "volume": "8",
      "year": "2005"
    },
    {
      "DOI": "10.1038/sj.onc.1202829",
      "author": "DH Gutmann",
      "doi-asserted-by": "crossref",
      "first-page": "4450",
      "issue": "31",
      "journal-title": "Oncogene",
      "key": "109_CR138",
      "unstructured": "Gutmann DH, Loehr A, Zhang Y, Kim J, Henkemeyer M, Cashen A. Haploinsufficiency for the neurofibromatosis 1 (NF1) tumor suppressor results in increased astrocyte proliferation. Oncogene. 1999;18(31):4450–9.",
      "volume": "18",
      "year": "1999"
    },
    {
      "DOI": "10.1038/sj.onc.1209264",
      "author": "M Wu",
      "doi-asserted-by": "crossref",
      "first-page": "2297",
      "issue": "16",
      "journal-title": "Oncogene",
      "key": "109_CR139",
      "unstructured": "Wu M, Wallace MR, Muir D. Nf1 haploinsufficiency augments angiogenesis. Oncogene. 2006;25(16):2297–303.",
      "volume": "25",
      "year": "2006"
    },
    {
      "DOI": "10.1593/neo.08312",
      "author": "T Ahlquist",
      "doi-asserted-by": "crossref",
      "first-page": "680",
      "issue": "7",
      "journal-title": "Neoplasia",
      "key": "109_CR140",
      "unstructured": "Ahlquist T, Bottillo I, Danielsen SA, Meling GI, Rognum TO, Lind GE, Dallapiccola B, Lothe RA. RAS signaling in colorectal carcinomas through alteration of RAS, RAF, NF1, and/or RASSF1A. Neoplasia. 2008;10(7):680–6. 682 p following 686.",
      "volume": "10",
      "year": "2008"
    },
    {
      "DOI": "10.1038/bjc.1994.404",
      "author": "L Cawkwell",
      "doi-asserted-by": "crossref",
      "first-page": "813",
      "issue": "5",
      "journal-title": "Br J Cancer",
      "key": "109_CR141",
      "unstructured": "Cawkwell L, Lewis FA, Quirke P. Frequency of allele loss of DCC, p53, RBI, WT1, NF1, NM23 and APC/MCC in colorectal cancer assayed by fluorescent multiplex polymerase chain reaction. Br J Cancer. 1994;70(5):813–8.",
      "volume": "70",
      "year": "1994"
    },
    {
      "DOI": "10.1038/bjc.1995.206",
      "author": "B Leggett",
      "doi-asserted-by": "crossref",
      "first-page": "1070",
      "issue": "5",
      "journal-title": "Br J Cancer",
      "key": "109_CR142",
      "unstructured": "Leggett B, Young J, Buttenshaw R, Thomas L, Young B, Chenevix-Trench G, Searle J, Ward M. Colorectal carcinomas show frequent allelic loss on the long arm of chromosome 17 with evidence for a specific target region. Br J Cancer. 1995;71(5):1070–3.",
      "volume": "71",
      "year": "1995"
    },
    {
      "DOI": "10.1038/nature11252",
      "author": "Cancer Genome Atlas N",
      "doi-asserted-by": "crossref",
      "first-page": "330",
      "issue": "7407",
      "journal-title": "Nature",
      "key": "109_CR143",
      "unstructured": "Cancer Genome Atlas N. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487(7407):330–7.",
      "volume": "487",
      "year": "2012"
    },
    {
      "DOI": "10.1016/j.celrep.2016.10.009",
      "author": "M Giannakis",
      "doi-asserted-by": "crossref",
      "first-page": "1206",
      "issue": "4",
      "journal-title": "Cell Rep",
      "key": "109_CR144",
      "unstructured": "Giannakis M, Mu XJ, Shukla SA, Qian ZR, Cohen O, Nishihara R, Bahl S, Cao Y, Amin-Mansour A, Yamauchi M, et al. Genomic correlates of immune-cell infiltrates in colorectal carcinoma. Cell Rep. 2016;17(4):1206.",
      "volume": "17",
      "year": "2016"
    },
    {
      "DOI": "10.1038/nature11282",
      "author": "S Seshagiri",
      "doi-asserted-by": "crossref",
      "first-page": "660",
      "issue": "7413",
      "journal-title": "Nature",
      "key": "109_CR145",
      "unstructured": "Seshagiri S, Stawiski EW, Durinck S, Modrusan Z, Storm EE, Conboy CB, Chaudhuri S, Guan Y, Janakiraman V, Jaiswal BS, et al. Recurrent R-spondin fusions in colon cancer. Nature. 2012;488(7413):660–4.",
      "volume": "488",
      "year": "2012"
    },
    {
      "DOI": "10.1146/annurev-pathol-011110-130235",
      "author": "ER Fearon",
      "doi-asserted-by": "crossref",
      "first-page": "479",
      "journal-title": "Annu Rev Pathol",
      "key": "109_CR146",
      "unstructured": "Fearon ER. Molecular genetics of colorectal cancer. Annu Rev Pathol. 2011;6:479–507.",
      "volume": "6",
      "year": "2011"
    },
    {
      "DOI": "10.1126/science.1235122",
      "author": "B Vogelstein",
      "doi-asserted-by": "crossref",
      "first-page": "1546",
      "issue": "6127",
      "journal-title": "Science",
      "key": "109_CR147",
      "unstructured": "Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz Jr LA, Kinzler KW. Cancer genome landscapes. Science. 2013;339(6127):1546–58.",
      "volume": "339",
      "year": "2013"
    },
    {
      "DOI": "10.1016/S0002-9440(10)65322-9",
      "author": "V Aaltonen",
      "doi-asserted-by": "crossref",
      "first-page": "755",
      "issue": "3",
      "journal-title": "Am J Pathol",
      "key": "109_CR148",
      "unstructured": "Aaltonen V, Bostrom PJ, Soderstrom KO, Hirvonen O, Tuukkanen J, Nurmi M, Laato M, Peltonen J. Urinary bladder transitional cell carcinogenesis is associated with down-regulation of NF1 tumor suppressor gene in vivo and in vitro. Am J Pathol. 1999;154(3):755–65.",
      "volume": "154",
      "year": "1999"
    },
    {
      "DOI": "10.1038/modpathol.2013.135",
      "author": "JS Ross",
      "doi-asserted-by": "crossref",
      "first-page": "271",
      "issue": "2",
      "journal-title": "Mod Pathol",
      "key": "109_CR149",
      "unstructured": "Ross JS, Wang K, Al-Rohil RN, Nazeer T, Sheehan CE, Otto GA, He J, Palmer G, Yelensky R, Lipson D, et al. Advanced urothelial carcinoma: next-generation sequencing reveals diverse genomic alterations and targets of therapy. Mod Pathol. 2014;27(2):271–80.",
      "volume": "27",
      "year": "2014"
    },
    {
      "DOI": "10.1111/j.1749-6632.1986.tb48062.x",
      "author": "JL Bader",
      "doi-asserted-by": "crossref",
      "first-page": "57",
      "journal-title": "Ann N Y Acad Sci",
      "key": "109_CR150",
      "unstructured": "Bader JL. Neurofibromatosis and cancer. Ann N Y Acad Sci. 1986;486:57–65.",
      "volume": "486",
      "year": "1986"
    },
    {
      "DOI": "10.1073/pnas.90.23.10914",
      "author": "AG Knudson",
      "doi-asserted-by": "crossref",
      "first-page": "10914",
      "issue": "23",
      "journal-title": "Proc Natl Acad Sci U S A",
      "key": "109_CR151",
      "unstructured": "Knudson AG. Antioncogenes and human cancer. Proc Natl Acad Sci U S A. 1993;90(23):10914–21.",
      "volume": "90",
      "year": "1993"
    },
    {
      "DOI": "10.1002/1097-0142(19931101)72:9\u003c2746::AID-CNCR2820720936\u003e3.0.CO;2-W",
      "author": "I Matsui",
      "doi-asserted-by": "crossref",
      "first-page": "2746",
      "issue": "9",
      "journal-title": "Cancer",
      "key": "109_CR152",
      "unstructured": "Matsui I, Tanimura M, Kobayashi N, Sawada T, Nagahara N, Akatsuka J. Neurofibromatosis type 1 and childhood cancer. Cancer. 1993;72(9):2746–54.",
      "volume": "72",
      "year": "1993"
    },
    {
      "DOI": "10.1016/j.cell.2006.01.016",
      "author": "S Wullschleger",
      "doi-asserted-by": "crossref",
      "first-page": "471",
      "issue": "3",
      "journal-title": "Cell",
      "key": "109_CR153",
      "unstructured": "Wullschleger S, Loewith R, Hall MN. TOR signaling in growth and metabolism. Cell. 2006;124(3):471–84.",
      "volume": "124",
      "year": "2006"
    },
    {
      "DOI": "10.1126/science.aai8690",
      "author": "L Chen",
      "doi-asserted-by": "crossref",
      "first-page": "752",
      "issue": "6326",
      "journal-title": "Science",
      "key": "109_CR154",
      "unstructured": "Chen L, Liu P, Evans Jr TC, Ettwiller LM. DNA damage is a pervasive cause of sequencing errors, directly confounding variant identification. Science. 2017;355(6326):752–6.",
      "volume": "355",
      "year": "2017"
    },
    {
      "DOI": "10.1073/pnas.1010978107",
      "author": "I Bozic",
      "doi-asserted-by": "crossref",
      "first-page": "18545",
      "issue": "43",
      "journal-title": "Proc Natl Acad Sci U S A",
      "key": "109_CR155",
      "unstructured": "Bozic I, Antal T, Ohtsuki H, Carter H, Kim D, Chen S, Karchin R, Kinzler KW, Vogelstein B, Nowak MA. Accumulation of driver and passenger mutations during tumor progression. Proc Natl Acad Sci U S A. 2010;107(43):18545–50.",
      "volume": "107",
      "year": "2010"
    },
    {
      "DOI": "10.1371/journal.pcbi.1004731",
      "author": "I Bozic",
      "doi-asserted-by": "crossref",
      "first-page": "e1004731",
      "issue": "2",
      "journal-title": "PLoS Comput Biol",
      "key": "109_CR156",
      "unstructured": "Bozic I, Gerold JM, Nowak MA. Quantifying clonal and subclonal passenger mutations in cancer evolution. PLoS Comput Biol. 2016;12(2):e1004731.",
      "volume": "12",
      "year": "2016"
    },
    {
      "DOI": "10.1073/pnas.1213968110",
      "author": "CD McFarland",
      "doi-asserted-by": "crossref",
      "first-page": "2910",
      "issue": "8",
      "journal-title": "Proc Natl Acad Sci U S A",
      "key": "109_CR157",
      "unstructured": "McFarland CD, Korolev KS, Kryukov GV, Sunyaev SR, Mirny LA. Impact of deleterious passenger mutations on cancer progression. Proc Natl Acad Sci U S A. 2013;110(8):2910–5.",
      "volume": "110",
      "year": "2013"
    },
    {
      "DOI": "10.1073/pnas.1404341111",
      "author": "CD McFarland",
      "doi-asserted-by": "crossref",
      "first-page": "15138",
      "issue": "42",
      "journal-title": "Proc Natl Acad Sci U S A",
      "key": "109_CR158",
      "unstructured": "McFarland CD, Mirny LA, Korolev KS. Tug-of-war between driver and passenger mutations in cancer and other adaptive processes. Proc Natl Acad Sci U S A. 2014;111(42):15138–43.",
      "volume": "111",
      "year": "2014"
    },
    {
      "DOI": "10.1016/j.sbi.2015.01.004",
      "author": "R Nussinov",
      "doi-asserted-by": "crossref",
      "first-page": "25",
      "journal-title": "Curr Opin Struct Biol",
      "key": "109_CR159",
      "unstructured": "Nussinov R, Tsai CJ. ‘Latent drivers’ expand the cancer mutational landscape. Curr Opin Struct Biol. 2015;32:25–32.",
      "volume": "32",
      "year": "2015"
    },
    {
      "DOI": "10.1038/nrc1299",
      "author": "PA Futreal",
      "doi-asserted-by": "crossref",
      "first-page": "177",
      "issue": "3",
      "journal-title": "Nat Rev Cancer",
      "key": "109_CR160",
      "unstructured": "Futreal PA, Coin L, Marshall M, Down T, Hubbard T, Wooster R, Rahman N, Stratton MR. A census of human cancer genes. Nat Rev Cancer. 2004;4(3):177–83.",
      "volume": "4",
      "year": "2004"
    },
    {
      "key": "109_CR161",
      "unstructured": "Network of Cancer Genes (NCG). http://ncg.kcl.ac.uk/ . Accessed Sept 2016."
    },
    {
      "DOI": "10.1038/nature12912",
      "author": "MS Lawrence",
      "doi-asserted-by": "crossref",
      "first-page": "495",
      "issue": "7484",
      "journal-title": "Nature",
      "key": "109_CR162",
      "unstructured": "Lawrence MS, Stojanov P, Mermel CH, Robinson JT, Garraway LA, Golub TR, Meyerson M, Gabriel SB, Lander ES, Getz G. Discovery and saturation analysis of cancer genes across 21 tumour types. Nature. 2014;505(7484):495–501.",
      "volume": "505",
      "year": "2014"
    },
    {
      "DOI": "10.1038/nature12213",
      "doi-asserted-by": "publisher",
      "key": "109_CR163",
      "unstructured": "Lawrence MS, Stojanov P, Polak P, Kryukov GV, Cibulskis K, Sivachenko A, Carter SL, Stewart C, Mermel CH, Roberts SA, et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature. 2013;499(7457):214–8. doi: 10.1038/nature12213 ."
    },
    {
      "DOI": "10.1038/nrc.2015.10",
      "author": "S Seton-Rogers",
      "doi-asserted-by": "crossref",
      "first-page": "5",
      "issue": "1",
      "journal-title": "Nat Rev Cancer",
      "key": "109_CR164",
      "unstructured": "Seton-Rogers S. Oncogenes: one of these things is not like the others. Nat Rev Cancer. 2016;16(1):5.",
      "volume": "16",
      "year": "2016"
    },
    {
      "DOI": "10.1038/nature10868",
      "author": "A Prahallad",
      "doi-asserted-by": "crossref",
      "first-page": "100",
      "issue": "7387",
      "journal-title": "Nature",
      "key": "109_CR165",
      "unstructured": "Prahallad A, Sun C, Huang S, Di Nicolantonio F, Salazar R, Zecchin D, Beijersbergen RL, Bardelli A, Bernards R. Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR. Nature. 2012;483(7387):100–3.",
      "volume": "483",
      "year": "2012"
    },
    {
      "DOI": "10.1007/s005950300074",
      "author": "K Furukawa",
      "doi-asserted-by": "crossref",
      "first-page": "323",
      "issue": "5",
      "journal-title": "Surg Today",
      "key": "109_CR166",
      "unstructured": "Furukawa K, Yanai N, Fujita M, Harada Y. Novel mutations of neurofibromatosis type 1 gene in small cell lung cancers. Surg Today. 2003;33(5):323–7.",
      "volume": "33",
      "year": "2003"
    },
    {
      "DOI": "10.1038/nature12965",
      "author": "Cancer Genome Atlas Research N",
      "doi-asserted-by": "crossref",
      "first-page": "315",
      "issue": "7492",
      "journal-title": "Nature",
      "key": "109_CR167",
      "unstructured": "Cancer Genome Atlas Research N. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014;507(7492):315–22.",
      "volume": "507",
      "year": "2014"
    },
    {
      "DOI": "10.1086/374821",
      "author": "T Raedt De",
      "doi-asserted-by": "crossref",
      "first-page": "1288",
      "issue": "5",
      "journal-title": "Am J Hum Genet",
      "key": "109_CR168",
      "unstructured": "De Raedt T, Brems H, Wolkenstein P, Vidaud D, Pilotti S, Perrone F, Mautner V, Frahm S, Sciot R, Legius E. Elevated risk for MPNST in NF1 microdeletion patients. Am J Hum Genet. 2003;72(5):1288–92.",
      "volume": "72",
      "year": "2003"
    },
    {
      "DOI": "10.1002/humu.21271",
      "author": "E Pasmant",
      "doi-asserted-by": "crossref",
      "first-page": "E1506",
      "issue": "6",
      "journal-title": "Hum Mutat",
      "key": "109_CR169",
      "unstructured": "Pasmant E, Sabbagh A, Spurlock G, Laurendeau I, Grillo E, Hamel MJ, Martin L, Barbarot S, Leheup B, Rodriguez D, et al. NF1 microdeletions in neurofibromatosis type 1: from genotype to phenotype. Hum Mutat. 2010;31(6):E1506–1518.",
      "volume": "31",
      "year": "2010"
    },
    {
      "DOI": "10.1038/nature10166",
      "author": "Cancer Genome Atlas Research N",
      "doi-asserted-by": "crossref",
      "first-page": "609",
      "issue": "7353",
      "journal-title": "Nature",
      "key": "109_CR170",
      "unstructured": "Cancer Genome Atlas Research N. Integrated genomic analyses of ovarian carcinoma. Nature. 2011;474(7353):609–15.",
      "volume": "474",
      "year": "2011"
    },
    {
      "DOI": "10.1038/nature07385",
      "author": "Cancer Genome Atlas Research N",
      "doi-asserted-by": "crossref",
      "first-page": "1061",
      "issue": "7216",
      "journal-title": "Nature",
      "key": "109_CR171",
      "unstructured": "Cancer Genome Atlas Research N. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008;455(7216):1061–8.",
      "volume": "455",
      "year": "2008"
    },
    {
      "DOI": "10.1001/jama.2009.1663",
      "author": "L Messiaen",
      "doi-asserted-by": "crossref",
      "first-page": "2111",
      "issue": "19",
      "journal-title": "JAMA",
      "key": "109_CR172",
      "unstructured": "Messiaen L, Yao S, Brems H, Callens T, Sathienkijkanchai A, Denayer E, Spencer E, Arn P, Babovic-Vuksanovic D, Bay C, et al. Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome. JAMA. 2009;302(19):2111–8.",
      "volume": "302",
      "year": "2009"
    },
    {
      "DOI": "10.1016/S0022-2836(03)00514-X",
      "author": "MR Ahmadian",
      "doi-asserted-by": "crossref",
      "first-page": "699",
      "issue": "4",
      "journal-title": "J Mol Biol",
      "key": "109_CR173",
      "unstructured": "Ahmadian MR, Kiel C, Stege P, Scheffzek K. Structural fingerprints of the Ras-GTPase activating proteins neurofibromin and p120GAP. J Mol Biol. 2003;329(4):699–710.",
      "volume": "329",
      "year": "2003"
    },
    {
      "DOI": "10.1074/jbc.271.27.16409",
      "author": "MR Ahmadian",
      "doi-asserted-by": "crossref",
      "first-page": "16409",
      "issue": "27",
      "journal-title": "J Biol Chem",
      "key": "109_CR174",
      "unstructured": "Ahmadian MR, Wiesmuller L, Lautwein A, Bischoff FR, Wittinghofer A. Structural differences in the minimal catalytic domains of the GTPase-activating proteins p120GAP and neurofibromin. J Biol Chem. 1996;271(27):16409–15.",
      "volume": "271",
      "year": "1996"
    },
    {
      "author": "H Ding",
      "first-page": "1106",
      "issue": "5",
      "journal-title": "Cancer Res",
      "key": "109_CR175",
      "unstructured": "Ding H, Shannon P, Lau N, Wu X, Roncari L, Baldwin RL, Takebayashi H, Nagy A, Gutmann DH, Guha A. Oligodendrogliomas result from the expression of an activated mutant epidermal growth factor receptor in a RAS transgenic mouse astrocytoma model. Cancer Res. 2003;63(5):1106–13.",
      "volume": "63",
      "year": "2003"
    },
    {
      "DOI": "10.1038/nature09208",
      "author": "Z Kan",
      "doi-asserted-by": "crossref",
      "first-page": "869",
      "issue": "7308",
      "journal-title": "Nature",
      "key": "109_CR176",
      "unstructured": "Kan Z, Jaiswal BS, Stinson J, Janakiraman V, Bhatt D, Stern HM, Yue P, Haverty PM, Bourgon R, Zheng J, et al. Diverse somatic mutation patterns and pathway alterations in human cancers. Nature. 2010;466(7308):869–73.",
      "volume": "466",
      "year": "2010"
    },
    {
      "DOI": "10.1038/nature12634",
      "author": "C Kandoth",
      "doi-asserted-by": "crossref",
      "first-page": "333",
      "issue": "7471",
      "journal-title": "Nature",
      "key": "109_CR177",
      "unstructured": "Kandoth C, McLellan MD, Vandin F, Ye K, Niu B, Lu C, Xie M, Zhang Q, McMichael JF, Wyczalkowski MA, et al. Mutational landscape and significance across 12 major cancer types. Nature. 2013;502(7471):333–9.",
      "volume": "502",
      "year": "2013"
    },
    {
      "DOI": "10.1002/path.4230",
      "author": "A Bashashati",
      "doi-asserted-by": "crossref",
      "first-page": "21",
      "issue": "1",
      "journal-title": "J Pathol",
      "key": "109_CR178",
      "unstructured": "Bashashati A, Ha G, Tone A, Ding J, Prentice LM, Roth A, Rosner J, Shumansky K, Kalloger S, Senz J, et al. Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profiling. J Pathol. 2013;231(1):21–34.",
      "volume": "231",
      "year": "2013"
    },
    {
      "DOI": "10.1038/ncomms4156",
      "author": "KL Kanchi",
      "doi-asserted-by": "crossref",
      "first-page": "3156",
      "journal-title": "Nat Commun",
      "key": "109_CR179",
      "unstructured": "Kanchi KL, Johnson KJ, Lu C, McLellan MD, Leiserson MD, Wendl MC, Zhang Q, Koboldt DC, Xie M, Kandoth C, et al. Integrated analysis of germline and somatic variants in ovarian cancer. Nat Commun. 2014;5:3156.",
      "volume": "5",
      "year": "2014"
    },
    {
      "DOI": "10.1016/j.ygyno.2013.06.019",
      "author": "JS Ross",
      "doi-asserted-by": "crossref",
      "first-page": "554",
      "issue": "3",
      "journal-title": "Gynecol Oncol",
      "key": "109_CR180",
      "unstructured": "Ross JS, Ali SM, Wang K, Palmer G, Yelensky R, Lipson D, Miller VA, Zajchowski D, Shawver LK, Stephens PJ. Comprehensive genomic profiling of epithelial ovarian cancer by next generation sequencing-based diagnostic assay reveals new routes to targeted therapies. Gynecol Oncol. 2013;130(3):554–9.",
      "volume": "130",
      "year": "2013"
    }
  ],
  "reference-count": 180,
  "references-count": 180,
  "resource": {
    "primary": {
      "URL": "http://humgenomics.biomedcentral.com/articles/10.1186/s40246-017-0109-3"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genomics"
  ],
  "source": "Crossref",
  "title": [
    "The NF1 somatic mutational landscape in sporadic human cancers"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "11"
}